Growth factor and cytokine receptor

Growth factor and cytokine receptors are membrane-bound proteins that bind extracellular signaling molecules called growth factors and cytokines. These receptors initiate intracellular signaling pathways that regulate vital cellular processes such as proliferation, differentiation, apoptosis, immune response, angiogenesis, and tissue repair[2][4][6]. Growth factor receptors are primarily receptor tyrosine kinases, while cytokine receptors include classes I, II, and III, each with characteristic ligand-binding and signal transduction mechanisms[7][10]. Dysfunction or dysregulation of these receptors is implicated in numerous diseases, most notably cancer and chronic inflammatory conditions[2][4]. Therapeutic agents targeting these receptors include monoclonal antibodies, kinase inhibitors, and biologics, which modulate receptor function directly or indirectly[4][9]. Because the nomenclature "Growth factor and cytokine receptors" refers collectively to many specific proteins, proper identification for research or clinical use requires specification of the exact receptor subtype. For structured data and accurate targeting, use individual receptor names, such as "Epidermal growth factor receptor (EGFR)", "Vascular endothelial growth factor receptor (VEGFR)", "Interleukin-6 receptor (IL-6R)", etc.

Other names

Growth factor receptorCytokine receptorReceptor tyrosine kinase (for many growth factor receptors, e.g. EGFR, VEGFR, FGFR)Interleukin receptor (for specific cytokine receptors)Interferon receptor

Blockade of ligand binding (antagonists/neutralizing antibodies); Inhibition of receptor tyrosine kinase activity (small-molecule inhibitors); Modulation of downstream signaling pathways (JAK/STAT inhibitors, MAPK/PI3K inhibitors); Targeted degradation or modulation (e.g. antibody-drug conjugates, bispecifics)